CB

Chandni Banerjee

Active Director Director DIN 09687786
DIN 09687786 First appointment Jul 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Chandni Banerjee

Data last updated:

Chandni Banerjee is a Director at Celoris Pharmaceuticals Private Limited (since 2022). The company operates in Trading. Celoris Pharmaceuticals Private Limited reported revenue of ₹1.11 Cr (FY 2024).

DIN 09687786
Primary Designation Director
Industry Trading
First Appointment 27 Jul 2022
Oldest Company Age 4 yrs
Largest company Celoris Pharmaceuticals Private Limited · ₹1.11 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jul 20222022₹1.11 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Celoris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Chandni Banerjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandni Banerjee

Chandni Banerjee currently holds 1 directorship: Celoris Pharmaceuticals Private Limited (Director, since 27 Jul 2022, revenue ₹1.11 Cr (FY 2024)).

Chandni Banerjee was first appointed on 27 Jul 2022 as Director at Celoris Pharmaceuticals Private Limited.

The current boards of Chandni Banerjee's companies include Amit Sharma Kumar (Celoris Pharmaceuticals Private Limited), Anil Kumar Sah (Celoris Pharmaceuticals Private Limited), Bijendra Kumar Gupta (Celoris Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available